Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes: Fading protection coincides with declining CD8 T cell numbers and phenotypic changes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes : Fading protection coincides with declining CD8 T cell numbers and phenotypic changes. / Jahn, Marie Louise; Steffensen, Maria Abildgaard; Christensen, Jan Pravsgaard; Thomsen, Allan Randrup.

In: Vaccine, Vol. 36, No. 20, 11.05.2018, p. 2825-2832.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jahn, ML, Steffensen, MA, Christensen, JP & Thomsen, AR 2018, 'Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes: Fading protection coincides with declining CD8 T cell numbers and phenotypic changes', Vaccine, vol. 36, no. 20, pp. 2825-2832. https://doi.org/10.1016/j.vaccine.2018.03.080

APA

Jahn, M. L., Steffensen, M. A., Christensen, J. P., & Thomsen, A. R. (2018). Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes: Fading protection coincides with declining CD8 T cell numbers and phenotypic changes. Vaccine, 36(20), 2825-2832. https://doi.org/10.1016/j.vaccine.2018.03.080

Vancouver

Jahn ML, Steffensen MA, Christensen JP, Thomsen AR. Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes: Fading protection coincides with declining CD8 T cell numbers and phenotypic changes. Vaccine. 2018 May 11;36(20):2825-2832. https://doi.org/10.1016/j.vaccine.2018.03.080

Author

Jahn, Marie Louise ; Steffensen, Maria Abildgaard ; Christensen, Jan Pravsgaard ; Thomsen, Allan Randrup. / Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes : Fading protection coincides with declining CD8 T cell numbers and phenotypic changes. In: Vaccine. 2018 ; Vol. 36, No. 20. pp. 2825-2832.

Bibtex

@article{9f8b7640195a42b383ab086a1adfe196,
title = "Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes: Fading protection coincides with declining CD8 T cell numbers and phenotypic changes",
abstract = "Defining correlates of T cell mediated protection is important in order to accelerate the development of efficient T cell based vaccines conferring long-term immunity. Extensive studies have provided important insight regarding the characteristics and functional properties of the effector and memory CD8 T cells induced by viral vector based vaccines. However, long-term protection has been difficult to achieve with T cell inducing vaccines, and the determinants underlying this loss in protection over time are still not fully defined. In this study we analyzed different parameters of the CD8 T cell response as a function of time after vaccination with a human serotype 5 adenovector expressing the glycoprotein (GP) of LCMV tethered to the MHC class II-associated invariant chain. Using this vector we have previously found that CD8 T cells mediate protection from challenge with GP-expressing Listeria monocytogenes at 60 days post vaccination, but only little protection after further 60 days, and we now confirm this observation. A comparison of vaccine-primed CD8 T cells early and late after vaccination revealed a minor decline in the overall numbers of antigen specific memory CD8 T cells during this interval. More importantly, we also observed phenotypic changes over time with a distinct decline in the frequency and number of KLRG1+ CD8 T cells, and, notably, adoptive transfer studies confirmed that memory CD8 T cells expressing KLRG1 are central to protection from systemic L. monocytogenes infection. Together these findings imply that multiple factors including changes in memory T cell numbers and phenotypic composition over time influence the longevity of CD8 T-cell mediated protection.",
author = "Jahn, {Marie Louise} and Steffensen, {Maria Abildgaard} and Christensen, {Jan Pravsgaard} and Thomsen, {Allan Randrup}",
note = "Copyright {\textcopyright} 2018 Elsevier Ltd. All rights reserved.",
year = "2018",
month = may,
day = "11",
doi = "10.1016/j.vaccine.2018.03.080",
language = "English",
volume = "36",
pages = "2825--2832",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier",
number = "20",

}

RIS

TY - JOUR

T1 - Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes

T2 - Fading protection coincides with declining CD8 T cell numbers and phenotypic changes

AU - Jahn, Marie Louise

AU - Steffensen, Maria Abildgaard

AU - Christensen, Jan Pravsgaard

AU - Thomsen, Allan Randrup

N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.

PY - 2018/5/11

Y1 - 2018/5/11

N2 - Defining correlates of T cell mediated protection is important in order to accelerate the development of efficient T cell based vaccines conferring long-term immunity. Extensive studies have provided important insight regarding the characteristics and functional properties of the effector and memory CD8 T cells induced by viral vector based vaccines. However, long-term protection has been difficult to achieve with T cell inducing vaccines, and the determinants underlying this loss in protection over time are still not fully defined. In this study we analyzed different parameters of the CD8 T cell response as a function of time after vaccination with a human serotype 5 adenovector expressing the glycoprotein (GP) of LCMV tethered to the MHC class II-associated invariant chain. Using this vector we have previously found that CD8 T cells mediate protection from challenge with GP-expressing Listeria monocytogenes at 60 days post vaccination, but only little protection after further 60 days, and we now confirm this observation. A comparison of vaccine-primed CD8 T cells early and late after vaccination revealed a minor decline in the overall numbers of antigen specific memory CD8 T cells during this interval. More importantly, we also observed phenotypic changes over time with a distinct decline in the frequency and number of KLRG1+ CD8 T cells, and, notably, adoptive transfer studies confirmed that memory CD8 T cells expressing KLRG1 are central to protection from systemic L. monocytogenes infection. Together these findings imply that multiple factors including changes in memory T cell numbers and phenotypic composition over time influence the longevity of CD8 T-cell mediated protection.

AB - Defining correlates of T cell mediated protection is important in order to accelerate the development of efficient T cell based vaccines conferring long-term immunity. Extensive studies have provided important insight regarding the characteristics and functional properties of the effector and memory CD8 T cells induced by viral vector based vaccines. However, long-term protection has been difficult to achieve with T cell inducing vaccines, and the determinants underlying this loss in protection over time are still not fully defined. In this study we analyzed different parameters of the CD8 T cell response as a function of time after vaccination with a human serotype 5 adenovector expressing the glycoprotein (GP) of LCMV tethered to the MHC class II-associated invariant chain. Using this vector we have previously found that CD8 T cells mediate protection from challenge with GP-expressing Listeria monocytogenes at 60 days post vaccination, but only little protection after further 60 days, and we now confirm this observation. A comparison of vaccine-primed CD8 T cells early and late after vaccination revealed a minor decline in the overall numbers of antigen specific memory CD8 T cells during this interval. More importantly, we also observed phenotypic changes over time with a distinct decline in the frequency and number of KLRG1+ CD8 T cells, and, notably, adoptive transfer studies confirmed that memory CD8 T cells expressing KLRG1 are central to protection from systemic L. monocytogenes infection. Together these findings imply that multiple factors including changes in memory T cell numbers and phenotypic composition over time influence the longevity of CD8 T-cell mediated protection.

U2 - 10.1016/j.vaccine.2018.03.080

DO - 10.1016/j.vaccine.2018.03.080

M3 - Journal article

C2 - 29627230

VL - 36

SP - 2825

EP - 2832

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 20

ER -

ID: 196744172